ACRS

NASD Aclaris Therapeutics, Inc.
Oct 9, 2026 · 9:33 PM ET EOD Market Closed

$3.83 ↑ +0.00 (+0.00%) Trading Up from the previous close of $3.83, $0.11 below the day’s high of $3.94

YTD change
+27.24%
vs 20-day SMA
-23.18%
vs 200-day SMA
-14.18%

Price ranges

Previous day
$3.18 $3.82
open $3.37 close $3.79
+$0.42 (+12.46%)
Today
$3.64 $3.94
open $3.76 now $3.83
+$0.07 (+1.86%)
Past week
$3.18 $4.52
from $4.41 now $3.83
-$0.58 (-13.15%)
Past month
$3.18 $5.77
from $5.51 now $3.83
-$1.68 (-30.43%)
This year
$2.49 $6.60
from $3.01 now $3.83
+$0.82 (+27.24%)

Price & Performance

-0.25 (-6.13%) / 6M

$3.15$4.36$5.57$6.79Apr 9Jul 10Oct 9

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral
  • The stock is 88.5% away from all-time highs of $33.25
  • ACRS is up 27% since the beginning of the year
  • ACRS is up 96% over the past 12 months
  • ACRS is down 30% over the past 1 month
  • 12% of all ACRS investors are betting against ACRS

ACRS reads neutral: price sits below both the 20- and 200-day averages, the 12-month move is +96.4%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.15
Earnings momentum +9.1% Quarterly EPS growth
Quarterly change +9.1%

Valuation

P/E ratio N/A
Enterprise value $451.3M
Beta 0.70

Balance sheet & scale

IncomeN/A
Revenue$8.2M
Cash$91.6M
Debt$1.9K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $563.8M

Aclaris Therapeutics, Inc. operates as a dermatologist-led biopharmaceutical company, which engages in identifying, developing, and commercializing novel drugs to address the needs in medical and aesthetic dermatology and immunology. The company was founded by Neal S. Walker, Frank Ruffo, Kamil Ali-Jackson, Christopher V. Powala, and Stuart D. Shanler in July 2012 and is headquartered in Wayne, PA.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $414.87 +1.82%
MRNA Moderna, Inc. $225.00 +14.21%
RVMD Revolution Medicines, Inc. $189.76 +0.87%
ROIV Roivant Sciences Ltd. $35.44 +3.60%
BNTX BioNTech SE Sponsored ADR $96.96 +5.32%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.